Fieldpoint Private Securities’s Teva Pharmaceuticals TEVA Stock Holding History

Fieldpoint Private Securities’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$4K	Sell	480 -2,523	-84%	-$22K	﹤0.01%	1005
2022 Q1	$28K	Buy	3,003 +3,000	+100,000%	+$25K	0.01%	753
2021 Q4	$0	Sell	3 -32	-91%	-$289	﹤0.01%	1735
2021 Q3	$0	Sell	35 -115	-77%	-$1.08K	﹤0.01%	1701
2021 Q2	$2K	Sell	150 -125	-45%	-$1.32K	﹤0.01%	1414
2021 Q1	$3K	Hold	275	–	–	﹤0.01%	1335
2020 Q4	$3K	Buy	+275	New	+$2.63K	﹤0.01%	1269
2019 Q3	–	Sell	-4,000	Closed	-$37K	–	726
2019 Q2	$37K	Hold	4,000	–	–	0.01%	453
2019 Q1	$63K	Hold	4,000	–	–	0.03%	276
2018 Q4	$62K	Hold	4,000	–	–	0.03%	267
2018 Q3	$86K	Hold	4,000	–	–	0.03%	268
2018 Q2	$97K	Sell	4,000 -800	-17%	-$16.3K	0.04%	262
2018 Q1	$82K	Sell	4,800 -5,100	-52%	-$99.6K	0.04%	253
2017 Q4	$188K	Buy	9,900 +200	+2%	+$3.01K	0.1%	167
2017 Q3	$171K	Buy	+9,700	New	+$218K	0.07%	207
2017 Q2	–	Sell	-199	Closed	-$6K	–	308
2017 Q1	$6K	Buy	+199	New	+$6.79K	﹤0.01%	322

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fieldpoint Private Securities's TEVA Position: Q2 2022 in Review

Fieldpoint Private Securities reduced its Teva Pharmaceuticals (TEVA) stake by 84% in Q2 2022, selling an estimated $22K and leaving 480 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #1005.

Fieldpoint Private Securities first reported a position in TEVA in Q1 2017 and has held it in 16 quarters since. The position peaked at $188K in Q4 2017. 456 funds tracked by Wall St. Rank hold TEVA as of Q2 2022.

Fieldpoint Private Securities held 480 shares of Teva Pharmaceuticals worth $4K as of Q2 2022.
Fieldpoint Private Securities sold 2,523 Teva Pharmaceuticals shares in Q2 2022, an estimated $22K.
Teva Pharmaceuticals made up ﹤0.01% of Fieldpoint Private Securities's portfolio in Q2 2022, its #1005 holding.
Fieldpoint Private Securities first reported a position in Teva Pharmaceuticals in Q1 2017 and has held it in 16 quarters since.
Fieldpoint Private Securities's Teva Pharmaceuticals position peaked at $188K in Q4 2017.
456 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2022.

Based on Fieldpoint Private Securities's 13F filing for Q2 2022, filed 5 Aug 2022.